Sopharma AD – Strategy, SWOT and Corporate Finance Report

Sopharma AD – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Sopharma AD (Sopharma) develops, manufactures and commercializes medicinal substances and finished dosage forms. The company focuses on the production of pharmaceutical products; substances and preparations; veterinary vaccines; infusion solutions; hemodialysis concentrates; medical disposable products; and injection molded products. It also performs research and development and implementation activities catering to the areas of phytochemistry, chemistry and pharmacy. Its key product portfolio consists of carsil, tempalgin, tabex, tribestan, broncholitin, analgin, nivalin and methylprednisolone. Geographically, the company distributes its products in Poland, Russia, Ukraine, Turkey, Georgia, Serbia, Belarus and other countries. Sopharma is headquartered in Sofia, Bulgaria.

Scope

Detailed information on Sopharma AD required for business and competitor intelligence needs

A study of the major internal and external factors affecting Sopharma AD in the form of a SWOT analysis

An in-depth view of the business model of Sopharma AD including a breakdown and examination of key business segments

News about Sopharma AD, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Sopharma AD and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Sopharma AD as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Sopharma ADs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Rigas Farmaceitiska Fabrika AS

Grindeks

Ecopharm BG

Arishop Pharma AD

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1 - About the Company 5

Sopharma AD - Key Facts 5

Sopharma AD - Key Employees 6

Sopharma AD - Key Employee Biographies 7

Sopharma AD - Major Products and Services 8

Sopharma AD - History 9

Sopharma AD - Locations And Subsidiaries 11

Head Office 11

Other Locations & Subsidiaries 11

Joint Venture 12

Section 2 Company Analysis 13

Company Overview 13

Sopharma AD - Business Description 14

Sopharma AD - SWOT Analysis 15

SWOT Analysis - Overview 15

Sopharma AD - Strengths 15

Sopharma AD - Weaknesses 16

Sopharma AD - Opportunities 17

Sopharma AD - Threats 18

Sopharma AD - Key Competitors 19

Section 3 Company Financial Ratios 20

Financial Ratios - Capital Market Ratios 20

Financial Ratios - Annual Ratios 21

Performance Chart 24

Financial Performance 24

Financial Ratios - Interim Ratios 25

Financial Ratios - Ratio Charts 26

Section 4 Company’s Lifesciences Financial Deals and Alliances 27

Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27

Sopharma AD, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28

Sopharma AD, Recent Deals Summary 29

Section 5 Company’s Recent Developments 30

Oct 26, 2017: Achieve Announces Exclusive, Long-term Manufacturing Agreement with Sopharma for Clinical and Commercial Supply of Cytisine 30

Section 6 Appendix 31

Methodology 31

Ratio Definitions 31

About GlobalData 35

Contact Us 35

Disclaimer 35

List of Tables

List of Tables

Sopharma AD, Key Facts 5

Sopharma AD, Key Employees 6

Sopharma AD, Key Employee Biographies 7

Sopharma AD, Major Products and Services 8

Sopharma AD, History 9

Sopharma AD, Subsidiaries 11

Sopharma AD, Joint Venture 12

Sopharma AD, Key Competitors 19

Sopharma AD, Ratios based on current share price 20

Sopharma AD, Annual Ratios 21

Sopharma AD, Annual Ratios (Cont…1) 22

Sopharma AD, Annual Ratios (Cont…2) 23

Sopharma AD, Interim Ratios 25

Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27

Sopharma AD, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28

Sopharma AD, Recent Deals Summary 29

Currency Codes 31

Capital Market Ratios 31

Equity Ratios 32

Profitability Ratios 32

Cost Ratios 33

Liquidity Ratios 33

Leverage Ratios 34

Efficiency Ratios 34

List of Figures

List of Figures

Sopharma AD, Performance Chart (2013 – 2017) 24

Sopharma AD, Ratio Charts 26

Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27

Sopharma AD, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports